Skip to main content
Published locations for Commentary: Abrocitinib, Malignancy Risk, and S aureus in AD, August 2023
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Commentary: Abrocitinib, Malignancy Risk, and S aureus in AD, August 2023
User login
Username
Password
Reset your password
/content/commentary-abrocitinib-malignancy-risk-and-s-aureus-ad-august-2023
/dermatology/article/264450/atopic-dermatitis/commentary-abrocitinib-malignancy-risk-and-s-aureus-ad